Results 191 to 198 of about 31,154 (198)
The Analyst, 1937 The article on ergot in this Handbook (vol. II, 2, pp. 1297–1354) was written by Arthur Cushny in 1914 but not published until 1924, without further revision. Thus a gap of more than two decades has now to be filled. In this interval the number of known ergot alkaloids has increased from two to eleven or twelve, all crystalline, and a considerable ...
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
1999
This volume provides readers with biotechnological aspects of ergot alkaloid production and genetic and physiological data.
Ladislav Cvak, Vladimir Kren
openaire +2 more sources
This volume provides readers with biotechnological aspects of ergot alkaloid production and genetic and physiological data.
Ladislav Cvak, Vladimir Kren
openaire +2 more sources
The Lancet, 1977
The systolic blood-pressure at the ankle and the first toe was measured in 30 patients, mean age 42, who had taken ergotamine regularly for more than a year. With one exception, the patients had no symptoms or signs of arterial insufficiency in the limbs, but all had low-normal or abnormal foot systolic blood-pressures.
H. Dige-Petersen +4 more
openaire +2 more sources
The systolic blood-pressure at the ankle and the first toe was measured in 30 patients, mean age 42, who had taken ergotamine regularly for more than a year. With one exception, the patients had no symptoms or signs of arterial insufficiency in the limbs, but all had low-normal or abnormal foot systolic blood-pressures.
H. Dige-Petersen +4 more
openaire +2 more sources
Bioconversions of ergot alkaloids [PDF]
, 1991 Ergot alkaloids are very important pharmaceutical substances with wide medical use. Their bioproduction is usually followed by chemical modification. Bioconversions of ergot alkaloids on an industrial scale have become more important in recent years.
openaire +2 more sources